 Bethany Veo
Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebellar Neoplasms | 3 | 2022 | 126 | 1.070 |
Why?
| | Medulloblastoma | 3 | 2022 | 171 | 1.050 |
Why?
| | Peptide Chain Initiation, Translational | 2 | 2012 | 28 | 0.830 |
Why?
| | tau Proteins | 2 | 2012 | 68 | 0.800 |
Why?
| | DNA Repair | 1 | 2021 | 189 | 0.750 |
Why?
| | RNA, Messenger | 3 | 2012 | 2748 | 0.520 |
Why?
| | Ribosome Subunits, Small, Eukaryotic | 1 | 2012 | 5 | 0.480 |
Why?
| | Repressor Proteins | 4 | 2019 | 397 | 0.470 |
Why?
| | Receptors, Dopamine D2 | 2 | 2019 | 113 | 0.340 |
Why?
| | Glioblastoma | 2 | 2019 | 252 | 0.280 |
Why?
| | Caenorhabditis elegans Proteins | 3 | 2013 | 227 | 0.270 |
Why?
| | Caenorhabditis elegans | 3 | 2013 | 345 | 0.200 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2021 | 122 | 0.200 |
Why?
| | Gene Expression Regulation | 2 | 2012 | 2525 | 0.190 |
Why?
| | RNA Cap Analogs | 2 | 2010 | 4 | 0.190 |
Why?
| | Neuroblastoma | 2 | 2012 | 141 | 0.190 |
Why?
| | Brain Neoplasms | 2 | 2019 | 975 | 0.190 |
Why?
| | Cell Proliferation | 3 | 2022 | 2368 | 0.180 |
Why?
| | Nucleic Acid Conformation | 2 | 2012 | 654 | 0.170 |
Why?
| | Locomotion | 1 | 2018 | 92 | 0.160 |
Why?
| | Corpus Striatum | 1 | 2018 | 166 | 0.150 |
Why?
| | Cell Line, Tumor | 3 | 2022 | 2898 | 0.150 |
Why?
| | Pharynx | 2 | 2013 | 52 | 0.140 |
Why?
| | SOXB1 Transcription Factors | 1 | 2015 | 61 | 0.140 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 335 | 0.140 |
Why?
| | Biomarkers, Tumor | 2 | 2019 | 1048 | 0.140 |
Why?
| | DNA-Binding Proteins | 3 | 2013 | 1382 | 0.140 |
Why?
| | Forkhead Transcription Factors | 1 | 2015 | 184 | 0.130 |
Why?
| | RNA, Small Interfering | 3 | 2015 | 587 | 0.130 |
Why?
| | Neural Stem Cells | 1 | 2015 | 106 | 0.130 |
Why?
| | Mice | 6 | 2021 | 15530 | 0.120 |
Why?
| | Animals | 10 | 2021 | 34332 | 0.120 |
Why?
| | Organogenesis | 1 | 2013 | 56 | 0.120 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2015 | 323 | 0.120 |
Why?
| | Pluripotent Stem Cells | 1 | 2012 | 66 | 0.110 |
Why?
| | RNA, Ribosomal | 1 | 2012 | 162 | 0.110 |
Why?
| | Embryonic Stem Cells | 1 | 2012 | 110 | 0.110 |
Why?
| | Nerve Tissue Proteins | 1 | 2015 | 584 | 0.100 |
Why?
| | Eukaryotic Initiation Factor-4G | 1 | 2010 | 4 | 0.100 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2010 | 23 | 0.100 |
Why?
| | Trans-Splicing | 1 | 2010 | 14 | 0.100 |
Why?
| | Protein Structure, Tertiary | 1 | 2012 | 840 | 0.100 |
Why?
| | Neurons | 1 | 2018 | 1419 | 0.090 |
Why?
| | Luciferases, Firefly | 1 | 2009 | 4 | 0.090 |
Why?
| | Luciferases, Renilla | 1 | 2009 | 4 | 0.090 |
Why?
| | Cycloheximide | 1 | 2009 | 61 | 0.090 |
Why?
| | MicroRNAs | 1 | 2015 | 624 | 0.090 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2009 | 48 | 0.090 |
Why?
| | Phosphorylation | 1 | 2012 | 1678 | 0.080 |
Why?
| | Rabbits | 1 | 2009 | 765 | 0.080 |
Why?
| | Alzheimer Disease | 1 | 2012 | 461 | 0.080 |
Why?
| | Transfection | 1 | 2009 | 910 | 0.070 |
Why?
| | Mutation | 2 | 2012 | 3406 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2009 | 2107 | 0.060 |
Why?
| | Humans | 7 | 2022 | 117481 | 0.060 |
Why?
| | Survival Rate | 2 | 2019 | 1807 | 0.060 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2022 | 41 | 0.060 |
Why?
| | Sequence Alignment | 2 | 2013 | 346 | 0.050 |
Why?
| | Apoptosis | 2 | 2022 | 2572 | 0.050 |
Why?
| | Quinazolines | 1 | 2022 | 246 | 0.050 |
Why?
| | Transcription Factors | 1 | 2009 | 1623 | 0.050 |
Why?
| | Piperazines | 1 | 2022 | 323 | 0.050 |
Why?
| | Prognosis | 2 | 2019 | 3540 | 0.050 |
Why?
| | Gene Knock-In Techniques | 1 | 2018 | 44 | 0.040 |
Why?
| | Pyrazoles | 1 | 2022 | 401 | 0.040 |
Why?
| | Cell Cycle Proteins | 1 | 2022 | 566 | 0.040 |
Why?
| | Neoplasm Invasiveness | 1 | 2019 | 456 | 0.040 |
Why?
| | Base Sequence | 2 | 2013 | 2170 | 0.040 |
Why?
| | Proto-Oncogene Proteins | 1 | 2022 | 682 | 0.040 |
Why?
| | Embryo, Mammalian | 1 | 2018 | 246 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2019 | 920 | 0.040 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2013 | 880 | 0.040 |
Why?
| | Molecular Sequence Data | 2 | 2013 | 2896 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2019 | 770 | 0.040 |
Why?
| | Models, Animal | 1 | 2018 | 380 | 0.040 |
Why?
| | Cell Differentiation | 2 | 2015 | 1790 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 413 | 0.040 |
Why?
| | Transduction, Genetic | 1 | 2015 | 125 | 0.030 |
Why?
| | Heterografts | 1 | 2015 | 127 | 0.030 |
Why?
| | Ligases | 1 | 2013 | 33 | 0.030 |
Why?
| | Mice, Nude | 1 | 2015 | 685 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2019 | 1193 | 0.030 |
Why?
| | Cerebellum | 1 | 2015 | 255 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2015 | 770 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2018 | 2102 | 0.030 |
Why?
| | Cell Dedifferentiation | 1 | 2012 | 30 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 2013 | 481 | 0.030 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2013 | 164 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2015 | 1017 | 0.030 |
Why?
| | Blotting, Western | 1 | 2015 | 1247 | 0.030 |
Why?
| | Zinc Fingers | 1 | 2012 | 45 | 0.030 |
Why?
| | Muscle Cells | 1 | 2012 | 43 | 0.030 |
Why?
| | Extracellular Space | 1 | 2012 | 140 | 0.030 |
Why?
| | RNA Interference | 1 | 2013 | 490 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2012 | 327 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1594 | 0.030 |
Why?
| | Microtubules | 1 | 2013 | 241 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2015 | 1755 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 2013 | 706 | 0.030 |
Why?
| | Cell-Free System | 1 | 2010 | 44 | 0.020 |
Why?
| | Male | 4 | 2019 | 60409 | 0.020 |
Why?
| | 5' Untranslated Regions | 1 | 2010 | 45 | 0.020 |
Why?
| | Guanosine | 1 | 2010 | 39 | 0.020 |
Why?
| | Cell Culture Techniques | 1 | 2012 | 352 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2013 | 2106 | 0.020 |
Why?
| | RNA Stability | 1 | 2010 | 103 | 0.020 |
Why?
| | Genomics | 1 | 2012 | 533 | 0.020 |
Why?
| | Protein Biosynthesis | 1 | 2010 | 383 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 6794 | 0.020 |
Why?
| | Phenotype | 1 | 2015 | 2868 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2015 | 4191 | 0.020 |
Why?
| | Cell Line | 1 | 2012 | 2832 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2015 | 3800 | 0.020 |
Why?
| | Child | 1 | 2022 | 18613 | 0.010 |
Why?
| | Female | 2 | 2019 | 63228 | 0.010 |
Why?
| | Biomarkers | 1 | 2012 | 3574 | 0.010 |
Why?
| | Time Factors | 1 | 2012 | 6905 | 0.010 |
Why?
| | Aged | 1 | 2019 | 20243 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2015 | 12318 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 28654 | 0.010 |
Why?
|
|
Veo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|